GP clinics are going to pay more payroll tax, which could reduce bulk billing

from The Conversation – health economics at https://bit.ly/44Dw037 on April 30, 2024 at 09:18PM stockfour/Shutterstock Preliminary bulk billing data released this week shows a 2.1% rise in bulk billing up to March. This comes after the government tripled the incentive payment for GPs to bulk bill concession-card holders and children under 16 for most consultations. […]

CMS pauses new data policy changes – Read on Washington’s April 2024 Advocacy Update

from AcademyHealth Blog at https://bit.ly/3w4Q6q9 on April 30, 2024 at 03:35PM CMS pauses new data policy changes – Read on Washington’s April 2024 Advocacy Update Appropriations Committees seeking outside witness testimony as they write their bills.  The House and Senate Appropriations Subcommittees on Labor and HHS have announced that they are accepting outside testimony for […]

Pharma, big pharma (20)

from Econsalut at https://bit.ly/3wet3Jh on April 30, 2024 at 11:53AM  Top companies and drugs by sales in 2023 Les grans companyies farmacèutiques de 2023 són les del gràfic. J&J ho encapçala en vendes i Merck en producte. Resulta interessant de veure el que ha aportat la vacuna a Pfizer durant el 2022, 38 mil milions […]

When supplies resume, should governments subsidise drugs like Ozempic for weight loss? We asked 5 experts

from The Conversation – health economics at https://bit.ly/3waw65n on April 29, 2024 at 09:04PM Rostislav_Sedlacek/Shutterstock Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually know about them? This month, The Conversation’s experts explore their rise, impact and potential consequences. You’ve no doubt heard of Ozempic […]